QPW
ITCI

Quantum Private Wealth’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Quantum Private Wealth’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-30,142
Closed -$2.52M – 185
2024
Q4 		$2.52M Sell
30,142
-8,519
-22% -$700K 0.81% 24
2024
Q3 		$2.83M Buy
38,661
+400
+1% +$30.1K 0.96% 16
2024
Q2 		$2.62M Buy
38,261
+1,062
+3% +$73.7K 0.93% 18
2024
Q1 		$2.57M Buy
37,199
+13,494
+57% +$927K 0.95% 18
2023
Q4 		$1.7M Buy
23,705
+9,308
+65% +$535K 0.71% 26
2023
Q3 		$750K Sell
14,397
-372
-3% -$21.7K 0.36% 67
2023
Q2 		$935K Sell
14,769
-125
-0.8% -$7.79K 0.43% 53
2023
Q1 		$807K Sell
14,894
-765
-5% -$37K 0.44% 52
2022
Q4 		$829K Sell
15,659
-941
-6% -$47.2K 0.53% 43
2022
Q3 		$772K Sell
16,600
-50,325
-75% -$2.63M 0.48% 43
2022
Q2 		$3.82M Sell
66,925
-6,847
-9% -$388K 2.25% 8
2022
Q1 		$4.51M Sell
73,772
-3,850
-5% -$200K 1.95% 9
2021
Q4 		$4.06M Buy
+77,622
New +$3.26M 1.54% 11

Other funds holding ITCI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Quantum Private Wealth's ITCI Position: Q1 2025 in Review

Quantum Private Wealth sold out of Intra-Cellular Therapies Inc. (ITCI) in Q1 2025, closing a stake of 30,142 shares — an estimated $2.52M sold.

Quantum Private Wealth first reported a position in ITCI in Q4 2021 and held it in 13 quarters. The position peaked at $4.51M in Q1 2022. 395 funds tracked by Wall St. Rank hold ITCI as of Q1 2025.

  • Quantum Private Wealth reported no remaining Intra-Cellular Therapies Inc. position as of Q1 2025 after selling out during the quarter.
  • Quantum Private Wealth sold 30,142 Intra-Cellular Therapies Inc. shares in Q1 2025, an estimated $2.52M.
  • Quantum Private Wealth first reported a position in Intra-Cellular Therapies Inc. in Q4 2021 and held it in 13 quarters.
  • Quantum Private Wealth's Intra-Cellular Therapies Inc. position peaked at $4.51M in Q1 2022.
  • 395 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q1 2025.

Based on Quantum Private Wealth's 13F filing for Q1 2025, filed 13 May 2025.